RAB9B and glioblastoma: Compared with normal tissues, RPL23A, EFNB1, NES, and EPHB4 expression markedly increased in GBM tissues, while CALB2, ENO2, OBSCN, RAB9B, and STMN2 were downregulated in GBM cases (Figures 4(a)–4(j)).